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INTRODUCTION
 Venous incompetence of the lower extremities 
is a very important issue, affecting 15% males 
and 25% females. Insufficiencies of the great 
saphenous veins (GSV) majorly contribute to the 
venous incompetence of the lower extremities.1-3 
This insufficiency may give rise to cosmetic 
concerns such as spider telangiectasia and varicose 
veins as well as to more serious problems such 
as limb edema, skin ulcers, and even some forms 
of disabilities.4 The main goal of therapy in GSV 
incompetence is to eliminate the underlying cause 
of venous reflux. The surgical option comprises 
high ligation and stripping combined with 
phlebectomy at the knee level.5 Surgery usually 
necessitates general anesthesia, and it may lead to 
certain morbidities such as hemorrhage, bleeding, 
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ABSTRACT
Objective: To assess the value of endovenous laser ablation (EVLA) for treating great saphenous vein (GSV) 
incompetence.
Methods: We reviewed the overall results of EVLA procedures performed on 554 patients in our clinic 
between	March	2011	and	December	2015.	Evaluations	were	made	concerning	the	situations	of	the	great	
saphenous vein (GSV), the energy used in the treatments, and the results obtained. We also investigated if 
there was a possibility to detect failure of EVLA treatment at an early stage. 
Results:	From	a	total	of	657	GSVs	that	were	subjected	to	EVLA	treatment,	the	procedure	was	found	to	be	
successful	for	611	GSVs	and	unsuccessful	for	46	GSVs	(success	rate:	93%).	In	38	of	the	46	GSVs,	a	thrombus	
formation	was	detected	by	color	Doppler	ultrasonography	(CDUS)	at	the	postoperative	first	month	(82.6%).
Conclusion: EVLA is a reliable and successful method utilized for the treatment of GSV incompetence. It is 
concluded	that	the	detection	of	a	thrombus	in	the	GSV	tract	during	the	first	postoperative	follow-up	month	
is an indicator for revascularization.
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pain, infection, neural damage, and scarring.3,6 
EVLA is a less invasive method than surgery, 
and it leads to lower morbidity rates, thereby 
impacting the quality of life in a positive manner.6 
EVLA, together with other endovenous thermal 
ablation techniques, has increasingly become a 
replacement for surgery. EVLA has been reported 
to be a successful modality, and its efficacy has 
been reported to be approximately 90%, in previous 
studies in the literature.3,7 In this retrospective study, 
we discuss the efficacy of EVLA in accordance 
with the literature. We also evaluate the impact of 
therapy together with the energy consumed during 
the procedure as well as the pre- and postoperative 
procedure steps utilized.
METHODS
Patient Selection: Patients who visited the 
Interventional Radiology Clinic of our hospital 
between March 2011 and December 2015 with 
complaints of limb varices, limb edema, and limb 
wounds were examined using color Doppler 
ultrasonography (CDUS). Those who were found to 
have GSV incompetence were recruited to undergo 
EVLA procedure. Prior to performing EVLA, the 
GSVs were examined using CDUS, and they were 
mapped. These maps demonstrated the lengths of 
the insufficient segment together with the diameter 
variations of the vessels. 
 Patients with a history of deep vein thrombosis 
(DVT) as well as patients suffering from deep vein 
insufficiencies and lower-extremity arterial diseases 
were excluded from the study.
Tumescent Anesthesia and Sedation: A mixture 
of 20 ml of 1% lidocaine, 1 mg adrenaline, 12.5 
meq bicarbonate, and 1000 cc saline solution 
was pumped into the perivascular spaces 
surrounding the affected GSVs. To perform this 
procedure all around the affected vessels, the tip 
of the application needle was maneuvered under 
ultrasonic guidance the needle was made to reach 
both the anterior and posterior sides of the vessels. 
Compression of the veins to achieve a thickness 
3–5 mm following administration of anesthetic 
fluid was established as a sign of satisfactory 
analgesia. A majority of our patients also received 
sedoanalgesia, comprising intravenous injection 
of Midazolam and Alfentanil.
EVLA Procedure: EVLA procedure was performed 
under ultrasonic guidance, immediately following 
sedoanalgesia and the onset of tumescence. The initial 
venous entrance was performed using a 21-gauge 
micropuncture needle set at an approximate level of 
10–20 cm above the ankle. For venous entrance, we 
used a 0.018-inch wire and a 5-French outer catheter 
measuring 10 cm in length in addition to the above-
mentioned 21-Gauge needle. A 0.035-inch J-tipped 
guidewire was passed through the needle and 
extended up to the saphenofemoral junction. Then, 
the laser sheath was introduced and passed over 
the guidewire, and the guidewire was extracted 
out. Finally, the laser wire was passed through the 
laser sheath. This laser wire was connected to the 
laser generator, which produced an 810-nm diode 
laser energy (MedArt A/S, Hvidovre, Denmark). 
The tip of the laser wire was stationarily placed at a 
level of approximately 1–2 cm distal to the terminal 
valve of the GSV. Following an optimal tumescent 
anesthesia, an active EVLA procedure phase was 
initiated and various laser energy ablations were 
applied to the GSV. The proximal segment of the 
GSV received laser energy at an intensity of 120–
140 J/cm, while the mid and distal thigh portions 
of the vessel received 100–120 J/cm; the knee-level 
segment, 80100 J/cm; and the sub-knee segment, 
approximately 60–80 J/cm. 
 Following the EVLA procedure, the patients 
were aided to wear a compression pantyhose and 
were instructed to keep wearing it for 2 days and to 
continue using it throughout the day for 4 weeks. 
The patients were also advised to walk daily for 30 
minutes.
Patient Follow-up: The patients were called for 
clinical follow-up and for undergoing Doppler US 
on the 1st, 3rd, 6th, 12th, and 24th month after receiving 
EVLA procedure, and their health conditions were 
recorded.
RESULTS
 A total of 657 incompetent GSVs of 553 patients 
were treated by means of the EVLA procedure; 104 
patients had bilateral VSM insufficiencies. The ages 
of the patients varied between 18 and 75 years, and 
their mean age was 40.5 years. Of the 553 patients, 
337 patients (61%) were females, while 216 (39%) 
were males. Demographic data as well as GSV 
dimensions and ablation energies utilized during 
the procedures are depicted in Table-I.
 The maximum diameter of the treated GSVs 
was 14.4 mm, and the minimum was 5.4 mm. The 
lengths of the treated segments of the GSVs varied 
between 22 mm and 65 mm. The applied laser 
energy intensities varied between 268 J and 4768 
J. The mean intensity of laser energy utilized was 
94.8 J/cm. 
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 At the end of 24 months, treatment to 611 GSVs 
was evaluated as successful and to 46 GSVs as 
unsuccessful. The success rate of the procedure was 
93%. In 38 of these 46 GSVs, thrombus formation 
had been detected using Doppler US during the 
first postoperative month (82.6%) (Table-II).
 None of our patients experienced complications 
such as DVT, skin burn, peripheral nerve damage, 
bleeding, or hematoma. One patient developed 
thrombophlebitis. Only 24 patients needed oral 
analgesics for postoperative pain. All of the patients 
were discharged on the day of the procedure.
 Fifty-five limbs of 44 patients were subjected 
to additional EVLA procedures for targeting the 
lesser saphenous veins (LSV), the accessory veins, 
or the perforating veins. Moreover, sclerotherapy 
was performed during the 6th month for treating 
resistant superficial varicose veins in patients in 
whom EVLA therapy had been unsuccessful.
DISCUSSION
 The Society for Vascular Surgery and the American 
Venous Forum both recommend that thermal 
ablation (EVLA or RFA) is a safe and effective 
method for the treatment of incompetent saphenous 
veins. US-guided foam sclerotherapy, bipolar 
radiofrequency (RF) ablation, cryostripping, and 
EVLA, are all less invasive methods compared with 
surgery.8 These modalities have a lower morbidity 
and recurrence rate as opposed to surgery, and 
their use is on the rise. The main purpose of every 
treatment method for incompetent saphenous 
veins is eradication of the underlying cause. The 
most frequently utilized endovascular method in 
this manner is EVLA. The general success rates of 
EVLA have been reported to be between 90% and 
95%, and our results is consistent with the literature 
data.
 During an EVLA procedure, the laser energy is 
absorbed by the vessel wall, and this absorption 
leads to tissue damage by means of photochemical 
and photothermolytic mechanisms. Transmural 
venous wall destruction causes irreversible 
occlusion of the vein, thereby producing a 
successful therapeutic result. The success of the 
EVLA procedure depends upon the infliction of 
sufficient irreversible vein wall destruction, which 
will in turn lead to contraction and subsequent 
fibrosis of the treated vein, instead of thrombosis 
which may give way to recanalization and thereby 
case treatment failure. 
 The amount of energy administered during the 
procedure may be one of the factors for unsuccessful 
treatment. Theivacumar et al have reported a 
successful GSV occlusion occurred when the energy 
intensity was >60 J/cm. The same authors have also 
reported that factors such as GSV diameter, ablated 
vein length, and body mass index had no effect on 
the outcome of therapy.9
 Tumescent anesthesia, too, increases the success 
rate of EVLA, by means of compressing the wall 
of the vein toward the laser energy fiber. It is 
recommended that 10 cc of tumescent anesthesia 
fluid should be injected circumferentially around 
the vein.10 Tumescent anesthesia is an important 
procedure not only for analgesia but also for 
preventing neural damage.11 Another collateral 
profit of tumescent anesthesia is the reduction in the 
amount of blood inside the vein. This leads to better 
energy transfer and consequent higher energy 
deposition on the vessel wall. If most of this energy 
is absorbed by blood alone, a thrombotic occlusion 
takes place which may lead to recanalization even 
months after the treatment. 
 EVLA has proved to have a lower recurrence rate 
compared with surgical ligation and stripping. In 
contrast to these gold standard surgical therapies 
for varicose veins, endovenous treatments do not 
require hospitalization and general anesthesia. 
EVLA procedures are usually performed under 
tumescent anesthesia and conscious sedation. 
Patients treated with the EVLA procedure usually 
resume work during the first postoperative 
week.12
 The major mechanism underlying post-procedural 
recanalization and reflux is thrombotic occlusion.13 It 
is believed that thrombus recanalization occurs over 
EVLA for treatment of great saphenous vein incompetence.
Table-I: The demographic data of the patients, together 
with the pre-procedural GSV sizes, and the laser 
energy intensities applied during the procedures.
Number of patients 553
Number of treated GSVs 657
Age 40.5 (18–75) years
Sex 337 (61%) 
 females; 216 (39%) males  
Length of treated GSV 39 (22–65) cm
Diameter of treated GSV 10.1 (5.4–14.4) mm
Laser energy intensity 94.8 (78.2–120) J/cm
Table-II: The EVLA success rate together with the 
frequency of encountering a thrombus during the 1st 
month in patients whom treatment is unsuccessful, 
which in turn reflects the recanalization rate.
EVLA success rate 93%
Recanalization due to thrombosis 82.6%
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a period of few months, similar to that occurring 
during DVT. Patients who were found to have 
thrombosis of the treated saphenous vein during 
the 1-month post-operative follow-up also had 
partial openings in the thrombus, and this finding 
was accepted as the precursor for recanalization. 
Insufficient tumescence anesthesia, insufficient 
application of laser energy to the vessel wall, and 
improper use of the compression pantyhose may be 
listed among the other probable causes of thrombus 
formation. Because our study was a retrospective 
one and also because the answers obtained from 
the patients regarding the use of pantyhose were 
subjective, no objective and substantial data could 
be extracted concerning this issue. We believe that a 
larger study series designed to conduct prospective 
analysis is warranted to draw better conclusions on 
this subject. 
 Complications such as pain, infection, bleeding, 
hematoma formation, DVT, nerve damage, and 
skin burn may be encountered following an EVLA 
procedure. All of these complications, except skin 
burns, can also be observed after surgery. However, 
Rustempasic et al have reported that infection, DVT, 
and hemorrhage are encountered less frequently 
after EVLA procedures than after surgery.14
 The structure of our study is more than competent 
in terms of patient population. However, we 
believe that large prospective studies involving 
other treatment modalities are needed to obtain 
maximum scientific data on this issue.
 Thus, we would like to conclude that EVLA is a 
very effective and reliable method for treating GSV 
incompetence. The detection of a thrombus in the 
vein during the postoperative 1st month follow-up 
is an indicator for recanalization. 
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